Literature DB >> 21306416

General principles of investigating and managing drug allergy.

Anthony Frew1.   

Abstract

Adverse reactions to medication are common. Some are predictable side-effects of the drug, others involve individual sensitivity to the drug. Allergic reactions are an important subset of these, but other specific sensitivities are caused by variations in the metabolism or mode of action of the drug. Patients who have experienced adverse reactions to medication will often refer to themselves as being allergic to the drug, regardless of the actual mechanism that caused the reaction. Consequently, anyone taking a history of 'drug allergy' needs to keep an open mind about the mechanism that may have been involved. Fortunately, most idiosyncratic reactions are minor, but some are severe, or even life-threatening. In most situations, there are satisfactory alternatives for the drug in question, but sometimes it is necessary to investigate and get an accurate diagnosis. The over-riding priority is to distinguish anaphylactic, potentially life-threatening reactions from other types of drug reaction, which are generally more protracted, less dangerous and usually managed by simple avoidance. While all doctors need to understand the underlying principles, drug challenges should only be undertaken by clinicians experienced in this area.
© 2011 The Author. British Journal of Clinical Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Year:  2011        PMID: 21306416      PMCID: PMC3093070          DOI: 10.1111/j.1365-2125.2011.03933.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

Review 1.  Dermatologic drug reactions.

Authors:  Jeffrey K McKenna; Kristin M Leiferman
Journal:  Immunol Allergy Clin North Am       Date:  2004-08       Impact factor: 3.479

2.  Evaluation of penicillin hypersensitivity: value of clinical history and skin testing with penicilloyl-polylysine and penicillin G. A cooperative prospective study of the penicillin study group of the American Academy of Allergy.

Authors:  G R Green; A H Rosenblum; L C Sweet
Journal:  J Allergy Clin Immunol       Date:  1977-12       Impact factor: 10.793

3.  Diagnosing immediate reactions to cephalosporins.

Authors:  A Romano; R-M Guéant-Rodriguez; M Viola; F Amoghly; F Gaeta; J-P Nicolas; J-L Guéant
Journal:  Clin Exp Allergy       Date:  2005-09       Impact factor: 5.018

Review 4.  Differential diagnosis of severe cutaneous drug eruptions.

Authors:  Nicolas Bachot; Jean-Claude Roujeau
Journal:  Am J Clin Dermatol       Date:  2003       Impact factor: 7.403

Review 5.  Delayed drug hypersensitivity reactions.

Authors:  Werner J Pichler
Journal:  Ann Intern Med       Date:  2003-10-21       Impact factor: 25.391

6.  Penicillin skin testing in patients with a history of beta-lactam allergy.

Authors:  Gonzalo Alvarez del Real; Mark E Rose; Maria T Ramirez-Atamoros; Jeffrey Hammel; Steven M Gordon; Alejandro C Arroliga; Mercedes E Arroliga
Journal:  Ann Allergy Asthma Immunol       Date:  2007-04       Impact factor: 6.347

7.  Diagnosing hypersensitivity reactions to cephalosporins in children.

Authors:  Antonino Romano; Francesco Gaeta; Rocco Luigi Valluzzi; Cristiana Alonzi; Marinella Viola; Philippe Jean Bousquet
Journal:  Pediatrics       Date:  2008-09       Impact factor: 7.124

8.  Skin test evaluation in nonimmediate allergic reactions to penicillins.

Authors:  M-J Torres; E Sánchez-Sabaté; J Alvarez; C Mayorga; J Fernández; A Padial; J-A Cornejo-García; T Bellón; M Blanca
Journal:  Allergy       Date:  2004-02       Impact factor: 13.146

9.  BSACI guidelines for the management of drug allergy.

Authors:  R Mirakian; P W Ewan; S R Durham; L J F Youlten; P Dugué; P S Friedmann; J S English; P A J Huber; S M Nasser
Journal:  Clin Exp Allergy       Date:  2009-01       Impact factor: 5.018

Review 10.  Delayed drug hypersensitivity reactions - new concepts.

Authors:  S J Posadas; W J Pichler
Journal:  Clin Exp Allergy       Date:  2007-07       Impact factor: 5.018

View more
  6 in total

Review 1.  Skin manifestations of drug allergy.

Authors:  Michael R Ardern-Jones; Peter S Friedmann
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

2.  Allergy, pseudo-allergy and non-allergy.

Authors:  Derek G Waller
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

3.  Evaluation of the potential sensitization of chlorogenic Acid: a meta-analysis.

Authors:  Mingbao Lin; Wan Gong; Qian Chen; Lijuan Sun; Yingchao Wang; Xiaohui Fan
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-16       Impact factor: 2.629

Review 4.  Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany.

Authors:  Marika Plöthner; Dana Ribbentrop; Jan-Phillipp Hartman; Martin Frank
Journal:  Adv Ther       Date:  2016-07-12       Impact factor: 3.845

5.  Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR.

Authors:  Carrie E Pierce; Sieta T de Vries; Stephanie Bodin-Parssinen; Linda Härmark; Phil Tregunno; David J Lewis; Simon Maskell; Raphael Van Eemeren; Alicia Ptaszynska-Neophytou; Victoria Newbould; Nabarun Dasgupta; Antoni F Z Wisniewski; Sara Gama; Peter G M Mol
Journal:  Drug Saf       Date:  2019-04       Impact factor: 5.606

6.  Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017.

Authors:  Kazeem Adeola Oshikoya; Ibrahim Abayomi Ogunyinka; Comfort Kunak Ogar; Abiodun Abiola; Ali Ibrahim; Ibrahim Adekunle Oreagba
Journal:  Ther Adv Drug Saf       Date:  2020-02-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.